Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	IMV	Decibel Therapeutics	Emblem	Neptune Wellness Solutions	Arix Bioscience
Symbol	TSE:IMV	NASDAQ:DBTX	CVE:EMC	TSE:NEPT	LON:ARIX
Price Information
Current Price	C$2.80	$6.76	$1.88	C$1.47	GBX 182
52 Week Range	Hold	Buy	N/A	Buy	Hold
MarketRank™
Overall Score	1.2	1.8	0.5	1.2	0.8
Analysis Score	3.0	4.5	0.0	3.5	0.0
Community Score	2.8	4.5	2.5	2.5	2.3
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.0
Earnings & Valuation Score	0.0	0.0	0.0	0.0	1.9
Analyst Ratings
Consensus Recommendation	Hold	Buy	N/A	Buy	Hold
Consensus Price Target	C$4.03	$27.20	N/A	C$5.50	N/A
% Upside from Price Target	44.05% upside	302.37% upside	N/A	274.15% upside	N/A
Trade Information
Market Cap	C$190.51 million	$162.61 million	$248.31 million	C$248.24 million	£244.03 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	141,348	140,957	865,800	546,997	267,984
Sales & Book Value
Annual Revenue	C$20,385.00	N/A	$5.71 million	C$52.78 million	£135.77 million
Price / Sales	9,312.18	N/A	43.02	4.61	1.79
Cashflow	C$0.45 per share	N/A	$0.46 per share	C$0.24 per share	GBX 132.87 per share
Price / Cash	6.23	N/A	4.08	6.03	1.37
Book Value	C$0.39 per share	N/A	$0.67 per share	C$0.92 per share	GBX 251.40 per share
Price / Book	7.11	N/A	2.82	1.60	0.01
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	C($0.52)	N/A	($0.19)	C($1.35)	GBX 88.70
Trailing P/E Ratio	N/A	0.00	N/A	N/A	2.05
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	$0.46	N/A	N/A
Dividend Yield	N/A	N/A	24.47%	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	30.78%	N/A	30.01%	3.75%	0.08%
Current Ratio	6.65%	N/A	3.61%	4.01%	78.63%
Quick Ratio	5.85%	N/A	3.24%	2.69%	78.01%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	77	40	N/A	165	12
Shares Outstanding	67.80 million	24.90 million	130.56 million	165.49 million	133.35 million
Next Earnings Date	8/11/2021 (Estimated)	8/12/2021 (Estimated)	N/A	6/8/2021 (Estimated)	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable

Source	Headline
	Arix Bioscience PLC: Notice of 2021 Annual General Meeting finanznachrichten.de - May 18 at 8:01 AM
	Autolus to present additional data in AUTO1 in IBCL finanztreff.de - May 14 at 11:40 PM
	Arix Bioscience PLC: Autolus to present additional data in AUTO1 in IBCL finanznachrichten.de - May 12 at 1:33 PM
	Acacia wins board changes at ex-Woodford stock Arix Bio citywire.co.uk - May 5 at 1:27 PM
	Amplyx Pharmaceuticals acquired by Pfizer uk.finance.yahoo.com - April 30 at 2:35 PM
	US buy-up firm advised by Neil Woodford takes control of British biotech investor standard.co.uk - April 30 at 2:35 PM
	Outcome of Strategic Implementation Review and Directorate Change uk.finance.yahoo.com - April 30 at 4:34 AM
	Arix Bioscience PLC: Outcome of Strategic Implementation Review and Directorate Change finanznachrichten.de - April 30 at 4:34 AM
	Arix Bioscience concludes strategic review, reshuffles board proactiveinvestors.co.uk - April 30 at 4:34 AM
	CORRECT (Apr 27): Arix portfolio firm partners with Daiichi, CANbridge lse.co.uk - April 28 at 10:21 AM
	Arix Bioscience PLC: Amplyx Pharmaceuticals acquired by Pfizer -2- finanznachrichten.de - April 28 at 10:21 AM
	Arix Bioscience's portfolio firm Amplyx snapped up by Pfizer proactiveinvestors.co.uk - April 28 at 10:21 AM
	Arix Bioscience (LON:ARIX) Stock Rating Reaffirmed by Shore Capital americanbankingnews.com - April 28 at 6:50 AM
	Arix Bioscience PLC: LogicBio announces clinical and corporate updates -2- finanznachrichten.de - April 27 at 1:34 PM
	Arix Bioscience investee LogicBio signs strategic collaboration with CANBridge Pharma proactiveinvestors.co.uk - April 27 at 1:34 PM
	American investor seeks board changes at Arix Bioscience thetimes.co.uk - April 26 at 7:31 PM
	Acacia looks to install its own directors in board shake-up of former Woodford biotech holding portfolio-adviser.com - April 26 at 9:30 AM
	Biotech group Arix prepares board shake-up in activist peace deal msn.com - April 22 at 1:15 PM
	Biotech group Arix prepares board shake-up in peace deal with activist Acacia news.sky.com - April 22 at 1:15 PM
	Arix Bioscience PLC : Arix to Present at the Proactive One2One Virtual Investor Forum markets.businessinsider.com - April 17 at 12:11 AM
	Shareholder broadside at biotech investor Arix’s board uk.finance.yahoo.com - April 10 at 3:58 PM
	Arix to Present at the Proactive One2One Virtual Investor Forum pharmiweb.com - April 8 at 9:12 AM
	Arix portfolio firm Artios Pharma to collaborate with Novartis on cancer therapy development proactiveinvestors.co.uk - April 7 at 8:35 AM
	Arix Bioscience PLC: Artios announces collaboration with Novartis to create next generation DDR cancer therapies finanznachrichten.de - April 7 at 8:35 AM
	Arix Bioscience PLC : Arix leads $152 million Series B financing for Pyxis Oncology markets.businessinsider.com - March 31 at 1:55 PM

Date	Company	Brokerage	Action
5/13/2021	IMV	Raymond James	Reiterated Rating
5/13/2021	IMV	National Bank Financial	Lower Price Target
5/13/2021	IMV	National Bankshares	Lower Price Target
3/18/2021	IMV	Leede Jones Gab	Reiterated Rating
3/31/2020	IMV	B. Riley	Downgrade
11/26/2019	IMV	Oppenheimer	Set Price Target
3/25/2019	IMV	HC Wainwright	Reiterated Rating
12/13/2018	IMV	Echelon Wealth Partners	Reiterated Rating
6/19/2018	IMV	Dawson James	Reiterated Rating
6/5/2018	IMV	Mackie	Boost Price Target
5/14/2021	Decibel Therapeutics	SVB Leerink	Lower Price Target
3/15/2021	Decibel Therapeutics	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Initiated Coverage
3/15/2021	Decibel Therapeutics	Barclays	Initiated Coverage
3/15/2021	Decibel Therapeutics	BMO Capital Markets	Initiated Coverage
12/4/2020	Neptune Wellness Solutions	Alliance Global Partners	Lower Price Target
5/17/2020	Neptune Wellness Solutions	Cowen	Boost Price Target
4/26/2021	Arix Bioscience	Shore Capital	Reiterated Rating
4/11/2019	Arix Bioscience	Stifel Nicolaus	Reiterated Rating
3/29/2019	Arix Bioscience	Jefferies Financial Group	Lower Price Target

(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources